buyModerate cluster of 2
Andrew Gengos bought $39k of TERN
Chief Financial Officer at Terns Pharmaceuticals, Inc.. 10,000 shares at an average of $3.93, traded Jun 27, 2025, filed Jun 30, 2025.
Conviction score
51Value
$39k
10,000 shares
Holdings after
25,000
+67% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +22RoleCFO
- +6Trade size$39k at market
- +10Relative to holdingsHoldings up 67%
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001562180-25-005120, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 27, 2025 | POpen-market purchase Common Stock | +5,000 | $3.93 | $20k | 20,000 | Jun 30, 2025 |
| Jun 27, 2025 | POpen-market purchase Common Stock | +5,000 | $3.93 | $20k | 25,000 | Jun 30, 2025 |
Related signals
Other insiders at Terns Pharmaceuticals, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 11Weak | Terns Pharmaceuticals, Inc. | Amy L. Burroughs Chief Executive Officer | $681k 14,583 shares | -5% | |
| 9Weak | Terns Pharmaceuticals, Inc. | Amy L. Burroughs Chief Executive Officer | $572k 14,583 shares | -5% | |
| 28Weak | Terns Pharmaceuticals, Inc. | Amy L. Burroughs Chief Executive Officer | $2.5M 68,749 shares | -19% | |
| 53Moderate | Terns Pharmaceuticals, Inc. | Amy L. Burroughs Chief Executive Officer | $2.7M 71,339 shares | -34% | |
| 29Weak | Terns Pharmaceuticals, Inc. | Emil Kuriakose Chief Medical Officer | $45k 1,155 shares | -2% | |
| 17Weak | Terns Pharmaceuticals, Inc. | Jill M. Quigley director | $441k 24,520 shares | -100% | |
| 15Weak | TERNsell Terns Pharmaceuticals, Inc. | Emil Kuriakose Chief Medical Officer | $7,407 944 shares | -2% | |
| 15Weak | TERNsell Terns Pharmaceuticals, Inc. | Emil Kuriakose Chief Medical Officer | $3,640 853 shares | -2% | |
| 52Moderate | Terns Pharmaceuticals, Inc. | Amy L. Burroughs Chief Executive Officer | $90k 23,314 shares | +98% | |
| 45Moderate | Terns Pharmaceuticals, Inc. | Andrew Gengos Chief Financial Officer | $57k 15,000 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.